These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19183760)

  • 21. Sildenafil for pulmonary arterial hypertension: exciting, but protection required.
    Mehta S
    Chest; 2003 Apr; 123(4):989-92. PubMed ID: 12684284
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhaled iloprost plus oral sildenafil in patients with severe pulmonary arterial hypertension delays the need for lung transplantation.
    Lopez-Meseguer M; Berastegui C; Monforte V; Bravo C; Domingo E; Roman A
    Transplant Proc; 2013; 45(6):2347-50. PubMed ID: 23953548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical use of sildenafil in pulmonary artery hypertension.
    Singh TP
    Expert Rev Respir Med; 2010 Feb; 4(1):13-9. PubMed ID: 20387288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sildenafil citrate therapy for pulmonary arterial hypertension.
    Galiè N; Ghofrani HA; Torbicki A; Barst RJ; Rubin LJ; Badesch D; Fleming T; Parpia T; Burgess G; Branzi A; Grimminger F; Kurzyna M; Simonneau G;
    N Engl J Med; 2005 Nov; 353(20):2148-57. PubMed ID: 16291984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of escalating doses of sildenafil on hemodynamics and gas exchange in children with pulmonary hypertension and congenital cardiac defects.
    Raja SG; Danton MD; MacArthur KJ; Pollock JC
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):203-7. PubMed ID: 17418732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension.
    Ramani GV; Park MH
    Drug Des Devel Ther; 2010 May; 4():61-70. PubMed ID: 20531962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience.
    Ruiz MJ; Escribano P; Delgado JF; Jiménez C; Tello R; Gómez MA; de la Calzada CS
    J Heart Lung Transplant; 2006 Nov; 25(11):1353-7. PubMed ID: 17097500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension.
    Stiebellehner L; Petkov V; Vonbank K; Funk G; Schenk P; Ziesche R; Block LH
    Chest; 2003 Apr; 123(4):1293-5. PubMed ID: 12684325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension.
    Mathai SC; Girgis RE; Fisher MR; Champion HC; Housten-Harris T; Zaiman A; Hassoun PM
    Eur Respir J; 2007 Mar; 29(3):469-75. PubMed ID: 17079256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study.
    Rubin LJ; Badesch DB; Fleming TR; Galiè N; Simonneau G; Ghofrani HA; Oakes M; Layton G; Serdarevic-Pehar M; McLaughlin VV; Barst RJ;
    Chest; 2011 Nov; 140(5):1274-1283. PubMed ID: 21546436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension.
    Suntharalingam J; Treacy CM; Doughty NJ; Goldsmith K; Soon E; Toshner MR; Sheares KK; Hughes R; Morrell NW; Pepke-Zaba J
    Chest; 2008 Aug; 134(2):229-236. PubMed ID: 18263674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study.
    Wilkins MR; Paul GA; Strange JW; Tunariu N; Gin-Sing W; Banya WA; Westwood MA; Stefanidis A; Ng LL; Pennell DJ; Mohiaddin RH; Nihoyannopoulos P; Gibbs JS
    Am J Respir Crit Care Med; 2005 Jun; 171(11):1292-7. PubMed ID: 15750042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension.
    Ghofrani HA; Rose F; Schermuly RT; Olschewski H; Wiedemann R; Kreckel A; Weissmann N; Ghofrani S; Enke B; Seeger W; Grimminger F
    J Am Coll Cardiol; 2003 Jul; 42(1):158-64. PubMed ID: 12849677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of sublingual sildenafil on pulmonary hypertension in patients with heart failure.
    Freitas AF; Bacal F; Oliveira Jde L; Santos RH; Moreira LF; Silva CP; Mangini S; Carneiro RM; Fiorelli AI; Bocchi EA
    Arq Bras Cardiol; 2009 Feb; 92(2):116-26. PubMed ID: 19360244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sildenafil for the treatment of pulmonary hypertension in pediatric patients.
    Huddleston AJ; Knoderer CA; Morris JL; Ebenroth ES
    Pediatr Cardiol; 2009 Oct; 30(7):871-82. PubMed ID: 19705181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sildenafil for primary pulmonary hypertension: short and long-term symptomatic benefit.
    Jackson G; Chambers J
    Int J Clin Pract; 2002 Jun; 56(5):397-8. PubMed ID: 12137450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of primary pulmonary hypertension with oral sildenafil.
    Karatza AA; Narang I; Rosenthal M; Bush A; Magee AG
    Respiration; 2004; 71(2):192-4. PubMed ID: 15031578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of oral sildenafil therapy on persistent pulmonary hypertension of the newborn at Queen Sirikit National Institute of Child Health.
    Khorana M; Yookaseam T; Layangool T; Kanjanapattanakul W; Paradeevisut H
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S64-73. PubMed ID: 22043756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension.
    Vachiery JL; Huez S; Gillies H; Layton G; Hayashi N; Gao X; Naeije R
    Br J Clin Pharmacol; 2011 Feb; 71(2):289-92. PubMed ID: 21219411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.
    Singh TP; Rohit M; Grover A; Malhotra S; Vijayvergiya R
    Am Heart J; 2006 Apr; 151(4):851.e1-5. PubMed ID: 16569546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.